TARA AROCHO: Open Payments
NPI 1649952953 · CHUBBUCK, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 29 payments from 6 companies in 2025. Trend: 2023 $197 · 2024 $934 · 2025 $808
Food & beverage: $808
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $260 |
| Vanda Pharmaceuticals Inc. | 8 | $155 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $136 |
| E.R. Squibb & Sons, L.L.C. | 2 | $136 |
| Alkermes, Inc. | 1 | $95 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
Products named: VRAYLAR, FANAPT, CAPLYTA, COBENFY, LYBALVI, REXULTI, QULIPTA.
Industry payments across ID — which companies pay providers there.
